retatrutide phase III study demonstrates 30% weight loss Retatrutide—A Game Changer in Obesity
Description
Inflammation and oxidative stress weaken the blood-brain barrier (BBB), allowing immune cells to infiltrate and aggravate the injury
Moreover, oral peptides come with a catch: they require much higher quantities of active ingredient than injectables to achieve similar efficacy
It is not approved for weight loss
Insurance Coverage, Prior Authorizations, and Access Coverage varies by insurance type and medical indication
doi: 10.1210/endo-125-6-3109
Pillars 13 , 100162 (2025)
